Eph receptor

From Wikipedia, the free encyclopedia

This article, image, template or category should belong in one or more categories. Please categorize it so it may be associated with related articles, images, templates or categories. Thank you.
Please remove this template after categorizing. This article has been tagged since November 2006.

}

The largest sub-family of Receptor Tyrosine Kinases is the Eph family, comprised of 16 known receptors (14 found in mammals) with 9 known ephrin ligands (8 found in mammals). The Eph receptors were initially identified in 1987 following a search for tyrosine kinases with possible roles in cancer, earning their name from the erythropoietin-producing hepatocellular carcinoma cell line from which their cDNA was obtained (Murai et al. 2003). These transmembranous receptors were initially classed as orphan receptors with no known ligands or functions and it was some time before possible functions of the receptors were known (Flanagan et al. 1998).

When it was shown that almost all Eph receptors were expressed during various well defined stages of development in assorted locations and concentrations, a role in cell positioning was proposed, initiating research that revealed the Eph/ephrin families as a principle cell guidance system during vertebrate and invertebrate development (Boyd et al. 2001).

1 Applications of the Eph guidance system
2 References
3 External links

[edit] Applications of the Eph guidance system

The ability of the Eph receptor and ephrin ligand guidance system to position cells and modulate cell morphology reflects their various roles in development.

[edit] Segmentation

Segmentation is a basic process of embryogenesis occurring in most invertebrates and all vertebrates by which the body is initially divided into functional units. In the segmented regions of the embryo, cells begin to present biochemical and morphological boundaries at which cell behavior is drastically different – vital for future differentiation and function (Holder et al. 1999). In the hindbrain segmentation is a precisely defined process, contrasted to the paraxial mesoderm, which is a dynamic and adaptive process that adjusts according to posterior body growth. Various Eph receptors and ephrins are expressed in these regions and through functional analysis it has been determined that Eph signaling is crucial for the proper development and maintenance of these segment boundaries (Holder et al. 1999). Similar studies conducted in zebrafish have shown similar segmenting processes within the somites containing a striped expression pattern of Eph receptors and their ligands which is vital to proper segmentation - the disruption of expression resulting in misplaced or even absent boundaries (Durbin et al. 1998).

[edit] Axon guidance and fasciculation

As the nervous system develops, the predefined patterning of neuronal connections is established by molecular guides that direct axons along pathways by target and pathway derived signals (Flanagan et al. 1998). Initial evidence arose via the receptor EphB2, expressed in several regions of the chick and mouse brain – having been immunolocalised to the surface of growth cones for spinal motor and occulomotor neurons from their origin toward their targets (Pasquale et al. 1992). Further evidence came with the role of Eph in topographic mapping in the visual system, with graded expression levels of both Eph receptors and ephrin ligands leading to the development of a resolved neuronal map (Cheng et al. 1995). Further studies then showed the role of Eph’s in topographic mapping in other regions of the central nervous system, such as learning and memory via the formation of projections between the septum and hippocampus (Gao et al. 1996).

[edit] Cell Migration

More than just axonal guidance, Eph’s have been implicated in the migration of neural crest cells during gastrulation (Robinson et al. 1997). In the chick and rat embryo trunk, the migration of crest cells is partially mediated by EphB receptors. Similar mechanisms have been shown to control crest movement in the hindbrain within rhombomeres 4, 5 and 7 which distribute crest cells to brachial arches 2, 3 and 4 respectively. In C. elegans a knockout of locus VAB-1, known to encode an Eph receptor, results in two cell migratory processes being affected (Holder et al. 1999).

[edit] Angiogenesis

The construction of blood vessels requires the coordination of endothelial and supportive mesenchymal cells through multiple phases to develop the intricate networks required for a fully functional circulatory system (Cheng et al. 2002). The dynamic nature and expression patterns of the Eph’s make them therefore ideal for roles in angiogenesis. Mouse embryonic models show expression of EphA1 in mesoderm and pre-endocardial cells, later spreading up into the dorsal aorta then primary head vein, intersomitic vessels and limb bud vasculature as would be consistent with a role in angiogenesis. Different class A Eph receptors have also been detected in the lining of the aorta, brachial arch arteries, umbilical vein and endocardium (Cheng et al. 2002). Complementary expression of EphB2/ephrin-B4 was detected in developing arterial endothelial cells and EphB4 in venous endothelial cells (Wang et al. 1998). Expression of EphB2 and ephrin-B2 was also detected on supportive mesenchymal cells, suggesting a role in wall development through mediation of endothelial-mesenchymal interactions (Adams et al. 1999). Blood vessel formation during embryogenesis consists of vasculogenesis, the formation of a primary capillary network followed by a second remodeling and restructuring into a finer tertiary network - studies utilizing ephrin-B2 deficient mice showed a disruption of the embryonic vasculature as a result of a deficiency in the restructuring of the primary network (Holder et al. 1999). Functional analysis of other mutant mice have led to the development of a hypothesis by which Eph’s and ephrins contribute to vascular development by restricting arterial and venous endothelial mixing, thus stimulating the production of capillary sprouts as well as in the differentiation of mesenchyme into perivascular support cells, an ongoing area of research (Cheng et al. 2002).

[edit] Limb Development

While there is currently little evidence to support this (and mounting evidence to refute it), some early studies implicated the Eph’s to play a part in the signaling of limb development (Holder et al. 1999). In chicks, EphA4 is expressed in the developing wing and leg buds, as well as in the feather and scale primordia (Patel et al. 1996). This expression is seen in the distal end of the limb buds, where cells are still undifferentiated and dividing, and appears to be under the regulation of retinoic acid, FGF2, FGF4 and BMP-2 – known to regulate limb patterning. EphA4 defective mice don’t present abnormalities in limb morphogenesis (personal communication between Andrew Boyd and Nigel Holder), so it is possible that these expression patterns are related to neuronal guidance or vascularisation of the limb with further studies being required to confirm or deny a potential role of Eph in limb development.

[edit] Cancer

As a member of the RTK family and with responsibilities as diverse as Eph’s, it is not surprising to learn that the Eph’s have been implicated in several aspects of cancer. While used extensively throughout development, Eph’s are rarely detected in adult tissues. Elevated levels of expression and activity have been correlated with the growth of solid tumors, with Eph receptors of both classes A and B being over expressed in a wide range of cancers including melanoma, breast, prostate, pancreatic, gastric, esophageal and colon cancer as well as hematopoietic tumors (Wicks et al. 1992; Kiyokawa et al. 1994; Easty et al. 1995). Increased expression was also correlated with more malignant and metastatic tumors, consistent with the role of Eph’s governing cell movement (Cheng et al. 2002).

It is possible that the increased expression of Eph in cancer plays several roles, firstly by acting as survival factors or as a promoter of abnormal growth (Surawska et al. 2004). The angiogenic properties of the Eph system may increase vascularisation of and thus growth capacity of tumors (Cheng et al. 2002). Secondly, elevated Eph levels may disrupt cell-cell adhesion via cadherin, known to alter expression and localisation of Eph receptors and ephrins which is known to further disrupt cellular adhesion, a key feature of metastatic cancers (Surawska et al. 2004). Thirdly, Eph activity may alter cell matrix interactions via integrins by the sequestering of signaling molecules following Eph receptor activation, as well as providing potential adherence via ephrin ligand binding following metastasis (Easty et al. 1995; Surawska et al. 2004).

[edit] References

Adams, R. H., G. A. Wilkinson, et al. (1999). "Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis." Genes & Development 13(3): 295-306.
Binns, K. L., P. P. Taylor, et al. (2000). "Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors." Molecular & Cellular Biology 20(13): 4791-805.
Boyd, A. W. and M. Lackmann (2001). "Signals from Eph and ephrin proteins: a developmental tool kit." Science's Stke [Electronic Resource]: Signal Transduction Knowledge Environment 2001(112): RE20.
Cheng, H. J., M. Nakamoto, et al. (1995). "Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map." Cell 82(3): 371-81.
Cheng, N., D. M. Brantley, et al. (2002). "The ephrins and Eph receptors in angiogenesis." Cytokine & Growth Factor Reviews 13(1): 75-85.
Davis, S., N. W. Gale, et al. (1994). "Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity." Science 266(5186): 816-9.
Durbin, L., C. Brennan, et al. (1998). "Eph signaling is required for segmentation and differentiation of the somites." Genes & Development 12(19): 3096-109.
Easty, D. J., M. Herlyn, et al. (1995). "Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis." International Journal of Cancer 60(1): 129-36.
Fantl, W. J., D. E. Johnson, et al. (1993). "Signalling by Receptor Tyrosine Kinases." Annual Review of Biochemistry 62(1): 453-481.
Flanagan, J. G. and P. Vanderhaeghen (1998). "The ephrins and Eph receptors in neural development." Annual Review of Neuroscience 21: 309-45.
Gao, P. P., J. H. Zhang, et al. (1996). "Regulation of topographic projection in the brain: Elf-1 in the hippocamposeptal system." Proceedings of the National Academy of Sciences of the United States of America 93(20): 11161-6.
Hattori, M., M. Osterfield, et al. (2000). "Regulated cleavage of a contact-mediated axon repellent." Science 289(5483): 1360-5.
Himanen, J. P., M. J. Chumley, et al. (2004). "Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.[see comment]." Nature Neuroscience 7(5): 501-9.
Himanen, J. P. and D. B. Nikolov (2003). "Eph signaling: a structural view." Trends in Neurosciences 26(1): 46-51.
Himanen, J. P., K. R. Rajashankar, et al. (2001). "Crystal structure of an Eph receptor-ephrin complex." Nature 414(6866): 933-8.
Holder, N. and R. Klein (1999). "Eph receptors and ephrins: effectors of morphogenesis." Development 126(10): 2033-44.
Holmberg, J. and J. Frisen (2002). "Ephrins are not only unattractive." Trends in Neurosciences 25(5): 239-243.
Hubbard, S. R. (2004). "Juxtamembrane autoinhibition in receptor tyrosine kinases." Nature Reviews Molecular Cell Biology 5(6): 464-71.
Hubbard, S. R., M. Mohammadi, et al. (1998). "Autoregulatory mechanisms in protein-tyrosine kinases." Journal of Biological Chemistry 273(20): 11987-90.
Janes, P. W., N. Saha, et al. (2005). "Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.[see comment]." Cell 123(2): 291-304.
Kiyokawa, E., S. Takai, et al. (1994). "Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors." Cancer Research 54(14): 3645-50.
Lawrenson, I. D., S. H. Wimmer-Kleikamp, et al. (2002). "Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling." Journal of Cell Science 115(Pt 5): 1059-72.
Levkowitz, G., H. Waterman, et al. (1999). "Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1." Molecular Cell 4(6): 1029-40.
Murai, K. K. and E. B. Pasquale (2003). "'Eph'ective signaling: forward, reverse and crosstalk." Journal of Cell Science 116(Pt 14): 2823-32.
Nagano, O., D. Murakami, et al. (2004). "Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation." Journal of Cell Biology 165(6): 893-902.
Pasquale, E. B., T. J. Deerinck, et al. (1992). "Cek5, a membrane receptor-type tyrosine kinase, is in neurons of the embryonic and postnatal avian brain." Journal of Neuroscience 12(10): 3956-67.
Patel, K., R. Nittenberg, et al. (1996). "Expression and regulation of Cek-8, a cell to cell signalling receptor in developing chick limb buds." Development 122(4): 1147-55.
Robinson, V., A. Smith, et al. (1997). "Roles of Eph receptors and ephrins in neural crest pathfinding." Cell & Tissue Research 290(2): 265-74.
Rodrigues, G. A. and M. Park (1994). "Oncogenic activation of tyrosine kinases." Current Opinion in Genetics & Development 4(1): 15-24.
Smith, F. M., C. Vearing, et al. (2004). "Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen." Journal of Biological Chemistry 279(10): 9522-31.
Stapleton, D., I. Balan, et al. (1999). "The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization." Nature Structural Biology 6(1): 44-9.
Surawska, H., P. C. Ma, et al. (2004). "The role of ephrins and Eph receptors in cancer." Cytokine & Growth Factor Reviews 15(6): 419-433.
Tanaka, M., D. Nanba, et al. (2004). "ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands." Journal of Biological Chemistry 279(40): 41950-9.
Toth, J., T. Cutforth, et al. (2001). "Crystal structure of an ephrin ectodomain." Developmental Cell 1(1): 83-92.
Vearing, C. J. and M. Lackmann (2005). ""Eph receptor signalling; dimerisation just isn't enough"." Growth Factors 23(1): 67-76.
Wang, H. U., Z. F. Chen, et al. (1998). "Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.[see comment]." Cell 93(5): 741-53.
Waterman, H. and Y. Yarden (2001). "Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases." FEBS Letters 490(3): 142-52.
Wicks, I. P., D. Wilkinson, et al. (1992). "Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines." Proceedings of the National Academy of Sciences of the United States of America 89(5): 1611-5.
Wiley, H. S. and P. M. Burke (2001). "Regulation of receptor tyrosine kinase signaling by endocytic trafficking." Traffic 2(1): 12-8.
Wimmer-Kleikamp, S. H., P. W. Janes, et al. (2004). "Recruitment of Eph receptors into signaling clusters does not require ephrin contact." Journal of Cell Biology 164(5): 661-6.
Wybenga-Groot, L. E., B. Baskin, et al. (2001). "Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region." Cell 106(6): 745-57.
Zimmer, M., A. Palmer, et al. (2003). "EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion.[see comment]." Nature Cell Biology 5(10): 869-78.